Efficacy and Safety of Pyrotinib in HER2 Positive Gastrointestinal Tumors
NCT04960943
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
60
Enrollment
OTHER
Sponsor class
Conditions
Gastrointestinal Tumor
Effect of Drug
Interventions
DRUG:
Pyrotinib with or without trastuzumab
Sponsor
Fudan University